99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET
- PMID: 12501023
- DOI: 10.1097/00006231-200301000-00018
99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET
Abstract
Parkinson's disease (PD) is a degeneration of the nigrostriatal dopaminergic pathway, leading to a selective loss of dopamine in the striatum. 99mTc-TRODAT-1 is a recently developed radiotracer that selectively binds to the dopamine transporters, which are significant because loss of these transporters corresponds with a loss of dopaminergic neurons. The present investigation compared 99mTc-TRODAT-1 single photon emission computed tomography (SPECT) with 18F-FDOPA positron emission tomography (PET) in the evaluation of PD using a primate model. Three monkeys, including one 6-hydroxydopamine lesioned PD model and two controls, were examined by both 99mTc-TRODAT-1 SPECT and 18F-FDOPA PET. For the PD monkey, expression of parkinsonian behaviour and 18F-FDOPA PET were used to evaluate the severity of the lesion. 99Tc-TRODAT-1 was prepared from a lyophilized kit. After intravenous injection of the radiotracer, SPECT was acquired over 4 h using a dual-head camera equipped with ultra-high resolution fan-beam collimators. Both uptake measurement and visual assessment were performed. Data were compared with motor behaviour and PET imaging. The striatal uptake in both healthy and PD monkeys increased continuously during the study, although the gradient of increase was less prominent in the diseased monkey. The increased uptake in the controls appeared to become blunt around 4 h after injection. A profound decrease of 99Tc-TRODAT-1 uptake was found in the striatum of the PD monkey compared with the controls (0.91 vs 2.16). In the PD monkey, the decrease of striatal uptake contralateral to the more affected side of the body was more prominent compared to the ipsilateral side (0.77 vs 1.06). In addition, greater loss occurred in the contralateral side of the putamen (0.54 vs 1.04). Changes of uptake ratios in the striatum and its subnuclei of the PD monkey were significantly correlated with those measured from PET. The loss of striatal uptake appeared greater in SPECT than the corresponding PET with both visual and uptake analyses. In conclusion, our data in a limited series of cases indicate that 99Tc-TRODAT-1 with a conventional nuclear medicine camera system may provide a suitable tool in evaluating parkinsonism in a primate model.
Similar articles
-
Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys.Nucl Med Biol. 2002 Jul;29(5):561-7. doi: 10.1016/s0969-8051(02)00303-7. Nucl Med Biol. 2002. PMID: 12088726
-
Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.J Nucl Med. 2003 Jul;44(7):999-1005. J Nucl Med. 2003. PMID: 12843212 Clinical Trial.
-
Comparative Performance of 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT Imaging in Patients With Parkinson's Disease, Parkinson-Plus Syndrome, and Essential Tremor.Clin Nucl Med. 2021 Feb 1;46(2):95-102. doi: 10.1097/RLU.0000000000003409. Clin Nucl Med. 2021. PMID: 33234920
-
Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.Neurophysiol Clin. 2001 Oct;31(5):321-40. doi: 10.1016/s0987-7053(01)00273-8. Neurophysiol Clin. 2001. PMID: 11817273 Review.
-
18F-FDOPA PET for the diagnosis of parkinsonian syndromes.Q J Nucl Med Mol Imaging. 2014 Dec;58(4):355-65. Epub 2014 Nov 4. Q J Nucl Med Mol Imaging. 2014. PMID: 25366711 Review.
Cited by
-
SPECT molecular imaging in Parkinson's disease.J Biomed Biotechnol. 2012;2012:412486. doi: 10.1155/2012/412486. Epub 2012 Mar 24. J Biomed Biotechnol. 2012. PMID: 22529704 Free PMC article. Review.
-
Autologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeys.Sci Rep. 2013 Sep 27;3:2786. doi: 10.1038/srep02786. Sci Rep. 2013. PMID: 24071770 Free PMC article.
-
Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson's disease in animal models.NPJ Parkinsons Dis. 2022 Dec 22;8(1):175. doi: 10.1038/s41531-022-00440-6. NPJ Parkinsons Dis. 2022. PMID: 36550118 Free PMC article.
-
99mTc-TRODAT-1 SPECT Imaging in Early and Late Onset Parkinson's Disease.Asia Ocean J Nucl Med Biol. 2017 Spring;5(2):114-119. doi: 10.22038/aojnmb.2017.8844. Asia Ocean J Nucl Med Biol. 2017. PMID: 28660222 Free PMC article.
-
PET Imaging in Movement Disorders.Semin Nucl Med. 2018 Nov;48(6):513-524. doi: 10.1053/j.semnuclmed.2018.07.006. Epub 2018 Aug 16. Semin Nucl Med. 2018. PMID: 30322477 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources